These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7901473)

  • 41. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Budesonide for induction of remission in Crohn's disease.
    Otley A; Steinhart AH
    Cochrane Database Syst Rev; 2005 Oct; (4):CD000296. PubMed ID: 16235274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corticosteroid-sparing treatments in patients with Crohn's disease.
    Plevy SE
    Am J Gastroenterol; 2002 Jul; 97(7):1607-17. PubMed ID: 12135008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease.
    Wilschanski M; Sherman P; Pencharz P; Davis L; Corey M; Griffiths A
    Gut; 1996 Apr; 38(4):543-8. PubMed ID: 8707085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current medical therapies for Crohn's disease in Japan].
    Munakata A; Haga Y
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role and importance of an elemental diet in the treatment of Crohn's disease in children].
    Nemrava-Cicak S
    Lijec Vjesn; 1992; 114(9-12):284-7. PubMed ID: 1343134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Basic diet in Crohn's disease].
    Stober B; Nützenadel W; Ullrich F
    Monatsschr Kinderheilkd; 1983 Oct; 131(10):721-4. PubMed ID: 6139745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
    D'Haens G; Baert F; van Assche G; Caenepeel P; Vergauwe P; Tuynman H; De Vos M; van Deventer S; Stitt L; Donner A; Vermeire S; Van De Mierop FJ; Coche JR; van der Woude J; Ochsenkühn T; van Bodegraven AA; Van Hootegem PP; Lambrecht GL; Mana F; Rutgeerts P; Feagan BG; Hommes D; ;
    Lancet; 2008 Feb; 371(9613):660-667. PubMed ID: 18295023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elemental diet in steroid-dependent and steroid-refractory Crohn's disease.
    O'Brien CJ; Giaffer MH; Cann PA; Holdsworth CD
    Am J Gastroenterol; 1991 Nov; 86(11):1614-8. PubMed ID: 1951239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
    Vermeire S; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska-Jarosinska M; Baranovsky A; Sike R; Stoyanova K; Tasset C; Van der Aa A; Harrison P
    Lancet; 2017 Jan; 389(10066):266-275. PubMed ID: 27988142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diet therapy in chronic inflammatory bowel disease: results from meta-analysis and randomized controlled trials].
    Galandi D; Allgaier HP
    Praxis (Bern 1994); 2002 Nov; 91(47):2041-9. PubMed ID: 12501499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A controlled double blind study of azathioprine in the management of Crohn's disease.
    Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
    Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005984. PubMed ID: 17636816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of infliximab in treatment of pediatric Crohn's disease in China].
    Luo Y; Yu J; Zhao H; Peng K; Lou J; Ma M; Chen J
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):688-92. PubMed ID: 25476432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.
    Gunasekeera V; Mendall MA; Chan D; Kumar D
    Dig Dis Sci; 2016 Apr; 61(4):1148-57. PubMed ID: 26809868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge.
    Raouf AH; Hildrey V; Daniel J; Walker RJ; Krasner N; Elias E; Rhodes JM
    Gut; 1991 Jun; 32(6):702-7. PubMed ID: 1905672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.